Travere Therapeutics Inc
TVTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.2B
Close$
Share Statistics
| Market cap | $5.20 Billion |
|---|---|
| Enterprise Value | $5.45 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.11 |
| Outstanding Shares | 91,868,862 |
Return
| Return on Equity | -44.87% |
|---|---|
| Return on Assets | -7.98% |
| Return on Invested Capital | -10.87% |
Valuation & Multiples
| P/E Ratio | -114.06 |
|---|---|
| PEG | 1140.23 |
| Price to Sales | 10.99 |
| Price to Book Ratio | 54.95 |
| Enterprise Value to Revenue | 10.16 |
| Enterprise Value to EBIT | -116.57 |
| Enterprise Value to Net Income | -123 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 3.32 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
$136.24 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
$157.27 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 71.82% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.49%▼ 105.84% |
|---|---|
| Total Invested | $234.78M▼ 92.20% |
| Investors Holding | 53▼ 226.00% |
ESG Score
No data